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Abstract 
Recent studies have shown that the NADPH oxidase participates in the generation of superoxide anion in non-phagocytic cells. Here 
we report he isolation and nucleotide sequence of a cDNA for the cytochrome b-558 a-subunit of the NADPH oxidase in rat vascular 
smooth muscle cells (VSMCs). The coding region of the cDNA was 93% homologous to mouse and 81% to human in nucleotide 
sequence and 96% homologous to mouse and 89% to human in the deduced amino acid sequence. Our results provide a tool with which 
to explore the mechanism of superoxide anion generation i rat VSMCs and other non-phagocytic cells. 
Keywords: Vascular smooth muscle; Superoxide anion; NADPH oxidase; Cytochrome b-558; cDNA cloning 
Superoxide anion formation has been mainly described 
as a specific function of phagocytes such as neutrophils, 
macrophages, and monocytes [1]. The generation of super- 
oxide anion is catalyzed by the membrane-bound multi- 
component NADPH oxidase system in phagocytes. This 
consists of two cytosolic 47 kDa and 67 kDa components 
(p47 phox and p67 phox) [2,3], a small-molecular-weight 
G-protein (rac-I or rac-2) [4,5], and a membrane-associ- 
ated cytochrome b-558. Cytochrome b-558 is a heme-car- 
tying heterodimer with a non-glycosylated 22 kDa a-sub- 
unit (p22 phox) and a glycosylated 91 kDa /3-subunit 
(gp91 phox), and functions as the final electron transporter 
from NADPH to oxygen in generating superoxide anion 
[6]. 
Recent studies have shown that the ability to generate 
superoxide anion is not limited to phagocytes. Superoxide 
anion generation has been demonstrated in non-phagocytic 
cells including B-lymphocytes [7], fibroblasts [8], glomeru- 
lar mesangial cells [9], smooth muscle cells [10], endothe- 
lial cells [11], and epithelial cells [12]. Furthermore, oxy- 
gen free radicals such as superoxide anion have been 
implicated in the pathogenesis of both hypertension and 
atherosclerosis [13]. Despite the potential importance of 
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superoxide anion, the pathways leading to its generation i
vascular cells remain unclarified. 
Recently, we reported that angiotensin II stimulates 
superoxide anion generation by activating both the NADH 
and NADPH oxidases in cultured rat vascular smooth 
muscle cells (VSMCs) [14]. Our data suggested that super- 
oxide anion may participate in the signal transduction 
system related to cell growth such as hypertrophy or 
hyperplasia. We hypothesized that the NADPH oxidase 
system may be composed of some of the same components 
as that of phagocytes, and wished to determine the exis- 
tence, expression and regulation of each of these compo- 
nents in VSMCs. 
We first sought o determine whether the mRNA of the 
cytochrome b-558 a-subunit is expressed in rat VSMCs. 
VSMCs were isolated from 200-250 g male Sprague- 
Dawley rat thoracic aorta by enzymatic digestion as de- 
scribed previously [15] and total RNA was isolated with 
the acid-phenol extraction method [16]. 
Reverse transcriptional polymerase chain reaction (RT- 
PCR) was carried out using GeneAmp RNA PCR Kit 
(Perkin Elmer). Single-stranded cDNA was prepared from 
total RNA of rat VSMCs with an oligo(dT) primer and 
reverse transcriptase by incubating for 30 min at 42°C. The 
resulting single-stranded cDNA was amplified using syn- 
thetic oligonucleotide primers based on the cytochrome 
b-558 a-subunit of mouse macrophage [17]; upstream 
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primer 5'-ATTCTCATCACTGGGGGCATCGTG-3' (54- 
77) and downstream primer 5'-TCCTTGGGTTTAG- 
GCTCAATGGGAG-3' (415-391). PCR amplification was 
performed with deoxynucleoside triphosphate and Taq 
DNA potymerase for 30 cycles; 1 rain at 95°C, 2 min at 
50°C and 1.5 min at 72°C. The PCR product migrated as a 
clear single band on gel electrophoresis and the molecular 
size was 360 bp, which is in accord with that expected 
from the mouse cDNA sequence [17]. 
After purification of the PCR product, Cycle Sequenc- 
ing was performed in one of four dideoxynucleoside 
triphosphate-containing reaction mixtures and 50 fmol pu- 
rified PCR product, 1.6 pmol of either sense or antisense 
[32p]-5' end-labeled primers identical to those used for 
(A) 
- 44 CCACGCGTCCGGGACCGAGCGGCTGCGTGTGCTGGGTCCTCACC 
1 ATG GGG CAG ATC GAG TGG GCC ATG TGG GCC AAC GAA CAG GCG CTG 
M G Q I E W A M W A N E Q A L 15 
46 GCA TCT GGC CTG ATC CTC ATC ACA GGG GGC ATC GTG GCT ACT GCG 
A S G L I L I T G G I V A T A 30 
91 GGA CGC TTC ACG CAG TGG TAC TTT GGT GCT TAC TCT ATT GTT GCA 
G R F T Q W Y F G A Y S I V A 45 
136 GGA GTG CTC ATC TGT CTG CTG GAG TAC CCC CGG GGA AAG AGG AAA 
G V L I C L L E Y P R G K R K 60 
181 AAG GGC TCC ACC ATG GAG CGG TGT GGA CAG AAG TAC CTG ACC GCT 
K G S T M E R C G Q K Y L T A 75 
226 GTG GTG AAG CTG TTC GGG CCC CTC ACC AGA AAT TAC TAC GTC CGG 
V V K L F G P L T R N Y Y V R 90 
271 GCT GTC CTC CAC TTA CTG CTG TCC GTG CCT GCA GGC TTC CTG CTG 
A V L H L L L S V P A G F L L 105 
316 GCC ACC ATC CTG GGG ACC GTC TGC TTG GCC ATT GCC AGT GTG ATC 
A T I L G T V C L A I A S V I 120 
361 TAC CTG CTG GCA GCC ATC CGG GGT GAG CAG TGG ACT CCC ATT GAG 
Y L L A A I R G E Q W T P I E 135 
406 CCT AAA CCC AAG GAG CGG CCG CAG GTT GGA GGC ACC ATC AAG CAG 
P K P K E R P Q V G G T I K Q 150 
451 CCA CCT ACC AAC CCC CCA CCC CGG CCA CCA GCG GAG GTC CGC AAG 
P P T N P P P R P P A E V R K 165 
496 AAG CCA AGT GAG GCC GAA GAG GAG GCA GCC TCG GCA GGA GGA CCC 
K P S E A E E E A A S A G G P 180 
541 CAG GTT AAC CCA ATT CCA GTG ACA GAT GAG GTC GTG TGA 
Q V N P I P V T D E V V 192 
580 CCTTCAGTGGCTCCTGCTTGAGTTTCCAAGGTGTTGCTCCCAGAGGGTGGTGATGCCCAC 
640 TGT~TAAACATGGTTAATAGCTGGTAAA 
(B) 
rat VSMCs 
mouse macrophage 
human neut roph i l  
rat VSMCs 
mouse macrophage 
human neut roph i l  
rat VSMCs 
mouse macrophage 
human neut roph i l  
MGQIEWAMWANEQALASGL IL ITGGIVATAGRFTQ.WVFGAYSIVAGVL I  
__***********************************************  
*************************************************  
t 
CLLEYPRGKRKKGSTMERCGQKYLTAVVKLFGPLTRNYYVRAVLHLLLS  
*************************************************  
*************************************************  
VPAGFLLAT ILGTVCLAIASVIYLLAAIRGEQWTPIEPKPKERPQVGGT 
*************************************************  
*************************************************  
rat VSMCs IKQP PTNPPP RPPAEVRKKP SEAEEEAASAGGP • • • QVNP IPVTDEVV 
mouse macrophage ************************************************  
human neut rophi l  * **********************************************  
Fig. 1. (A) Nucleotide sequence of the cDNA and deduced amino-acid sequence of cytochrome b-558 a-subunit of rat VSMCs. The 5' untranslated 
nucleotide sequence is negatively numbered from the first base upstream of the initiator codon. A potential polyadenylation signal in the 3' untranslated 
region is underlined. (B) Alignment of the amino acid sequences of the cytochrome b-558 a-subunit of rat VSMCs, mouse macrophages [17], and human 
neutrophils [18]. * Amino acid residues identical among the three species. • Indicates the positions of amino acids which are found only in the human 
neutrophil, t Indicates potential phosphorylation sites by protein kinase C. :1: Indicates the putative heme-carrying histidine residue. 
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PCR, 2 units of AmpliTaq DNA polymerase, 40 /zM 
7-deaza-dGTP, 20 /xM dATP, 20 p~M dTTP, and 20 /zM 
dCTP (AmpliTaq Cycle Sequencing Kit, Perkin Elmer). 
The reaction conditions were as follows: 1 min at 95°C for 
1 cycle and 1 min at 95°C, 2 min at 50°C, and 1.5 min at 
72°C for 20 cycles. Primer 5' end labeling was performed 
with l0 /zCi [T-32p]ATP and 30 units of T4 polynu- 
cleotide kinase. The reaction products were loaded on 6% 
polyacrylamide gel electrophoresis and exposed to film at 
-80°C. Sequencing was performed on three separate 
preparations. 
Direct sequencing showed that the PCR product exhib- 
ited very high similarity with the mouse cDNA sequence 
between the upstream and downstream primers. Northern 
blotting analysis of rat VSMCs using the PCR product as a 
probe resulted in detection of a single band of molecular 
size 0.8 kb. This size is in agreement with the size of 
cytochrome b-558 a-subunit mRNA in human [18] and 
mouse [17]. No other sequence in GenBank was similar to 
the PCR product, except for those of cytochrome b-558 
c~-subunits. Therefore, the PCR product was considered to 
be specific and was used to screen a cDNA library of rat 
VSMCs. 
We used a size-fractionated cDNA library of rat VSMCs 
which is cloned at the Not I -Sa l I  sites of the pSPORT 
vector [19]. Approximately 5 • l0  4 independent clones were 
screened on membranes with the [32P]dCTP-labeled PCR 
product fragments. Nine positive clones were obtained 
during the secondary screening. Double-stranded cDNA 
inserted in pSPORT was sequenced after alkaline denatura- 
tion by the dideoxynucleotide chain termination method 
[20] using Sequenase Version 2.0 (United States Biochemi- 
cal). Only one clone coded the full length rat cytochrome 
b-558 a-subunit. The T7 and SP6 promoter primers (Pro- 
mega) and four additional synthetic oligonucleotide primers 
from partial sequence data were used to obtain complete 
sequence in both directions. 
Fig. I A shows the nucleotide sequence and the deduced 
amino acid sequence of rat cytochrome b-558 a-subunit. 
The sequence of 709 nucleotides reveals a 579-nucleotide 
open reading frame extending from the start codon ATG to 
the termination codon TGA. A consensus polyadenylation 
signal AATAAA is present at position 643-648. This 
cDNA sequence ncodes a 192-amino-acid protein with an 
estimated molecular weight of 20 745. Comparison of the 
deduced amino acid sequence with those of the cy- 
tochrome b-558 c~-subunit of human neutrophil and mouse 
macrophage is shown in Fig. lB. The coding regions of 
the rat cytochrome b-558 c~-subunit conserve 93% homol- 
ogy with mouse and 81% with human in the nucleotide 
(A) (B) 
4.8kb  = "28 S 
1.9 kb - 
0.8 kb " 
-18  S 
> 
I1) 
e-- 
Q .  
2 
E 
0 
E 
< 
Fig. 2. Northern blotting analysis. (A) mRNA expression f the cytochrome b-558 a-subunit inrat VSMCs and mouse macrophage cell line, RAW 264.7. 
l0/xg of total RNA was loaded in each lane. (B) mRNA expression in various rat tissues. Twenty/xg of total RNA was loaded in each lane. Samples were 
separated byelectrophoresis on 1% denaturing formaldehyde agarose gels and transferred to nylon membranes. Blots were probed with the whole length 
rat VSMC cDNA of the cytochrome b-558 o~-subunit. 
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sequence, and 96% with mouse and 89% with human in 
the deduced amino acid sequence. In the human neu- 
trophil, 2 or 3 tool of heme can be associated with a 
heterodimer of cytochrome b-558 [21]. A histidine residue 
(His-94) has been proposed to be the heme-carrying site, 
since the region which contains His-94 has homology with 
the heme-carrying region of mitochondrial cytochrome c 
oxidase [18]. In the deduced amino acid sequence of rat 
cDNA, not only is His-94 conserved, but also the sequence 
containing His-94 is in good agreement with those of the 
possible heme-carrying regions in the human and mouse. 
There are two protein kinase C phosphorylation consensus 
sequences: KXXS (X = any amino acid residue) at posi- 
tion 60-63, and TXK (X = hydrophobic residue) at posi- 
tion 147-149 [22]. These sequences are also present in the 
human and mouse. The amino acid sequence of the N- 
terminal half was well conserved in rat, mouse and human 
cDNAs. Twelve amino acid residues in the C-terminal 
region from Gln-181 to Val-192 were also well conserved 
in the three species, whereas the preceding sequence from 
Ala-170 to Gln-181 showed the least homology among 
human, rat and mouse. A deletion of 3 amino acids in the 
rat and mouse sequences was found in the latter region. 
Amino acid mutations (e.g., Arg-90--> Gln, Ser-118 
Arg, Pro-156 ~ Gln and His-94 ~ Arg) that have been 
found in chronic granulomatous disease patients [23-25] 
were not found in the deduced amino acid sequence of rat 
cDNA. 
Fig. 2A shows Northern blotting analysis of rat VSMC 
and mouse macrophage mRNA. A single band of 0.8 kb 
was observed in mRNA of rat VSMCs. This molecular 
size is in good agreement with those previously reported in 
human and mouse mRNAs. The relative level of expres- 
sion of this mRNA was lower in rat VSMCs than in mouse 
macrophages. Fig. 2B shows the tissue distribution of 
cytochrome b-558 c~-subunit mRNA expression in rat. 
This mRNA was expressed not only in lymphocytic tissues 
such as spleen and thymus, but also in non-lymphocytic 
tissues including aorta, lung, kidney, adrenals, and heart. 
The relative expression level of mRNA was considerably 
higher in kidney and lung than in aorta, adrenals, and 
heart. In contrast, mRNA expression was not detectable in
liver or brain. The same 0.8 kb band was observed in all 
rat tissues except he kidney which also expressed a smaller 
detectable band. 
Fig. 3 shows the results of Southern blotting analysis of 
rat genomic DNA. After digestion by restriction enzymes 
which do not cleave the cDNA sequence of rat cytochrome 
b-558 a-subunit, genomic DNA was probed under low 
stringency condition. Each digested sample showed a sin- 
gle band, except samples cut by HindlII or a combination 
of HindlII and BamHI. The fact that HindlII-cut samples 
showed two bands may indicate that the gene has one 
restriction site in an intron. These findings suggest hat 
only one gene encodes the cytochrome b-558 a-subunit in 
rat, which is compatible with the observation that human 
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Fig. 3. Southern blotting analysis. Genomic DNA was purified from rat 
VSMCs with the QIAamp tissue kit (QIAGEN). 20/zg genomic DNA of 
rat VSMCs was digested with BamHI, HindllI, EcoRI, XbaI or Nsil, or 
a combination of BamHI and HindllI or EcoRI and Xbal. The digested 
samples were separated on a 0.7% agarose gel and transferred to a nylon 
membrane. Blots were probed with the whole-length rat VSMC cDNA of 
the cytochrome b-558 c~-subunit. 
cytochrome b-558 o~-subunit is derived from a single locus 
at 16q24 [23]. 
In the present study, we have shown that the rat cDNA 
of the cytochrome b-558 o~-subunit conserved high homol- 
ogy with those of human and mouse, and that the mRNA 
of the cytochrome b-558 ce-subunit was expressed in rat 
VSMCs as well as rat non-phagocytic tissues. Although 
earlier studies have suggested that the /3-subunit of cy- 
tochrome b-558 is important to the stability of both o~-and 
/3-subunits, and to the catalytic activity of enzyme as a 
whole [18,26,23], the function of the cytochrome b-558 
c~-subunit is not well understood, especially in non- 
phagocytic ells. Future studies will be focused on the 
exploration of the functional consequences of mRNA ex- 
pression of the cytochrome b-558 a-subunit and its role in 
superoxide anion generation i  VSMCs in both normal and 
pathological states. 
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